.Faculty: Michael S. Blaiss, MD, and Phillip Lieberman, MD
Target Audience:This educational activity was designed to
educate allergists, pediatricians, and primary care physicians who have
an interest in the various clinical presentations of allergic rhinitis
and approaches to therapy.
Fee: There is no charge for participating in this educational activity.
Term of Offering: Category 1 CME credit for this Internet
monograph will be available through
December 15, 2002. The original release date of this material was
December 15, 2001. Continuing education credit is offered upon
successful completion of the post-test.
Upon successful completion of the post-test
(a score of 70% or better), evaluation form, and enrollment form, you
may print out your certificate. If you have any questions, please call
the Pragmaton Office of Medical Education
Emerging Clinical Considerations in Allergic Rhinitis
Faculty BiographiesMichael S. Blaiss, MD
Clinical Professor of Pediatrics and Medicine
University of Tennessee College of Medicine
Memphis, Tennessee
Phillip Lieberman, MD
Clinical Professor of Pediatrics and Medicine
University of Tennessee College of Medicine
Memphis, Tennessee
Back to TopLearning Objectives
Upon completion of this program, participants should be able to:
Discuss how snoring relates to nasal obstruction and disordered sleeping
Explain the impact of gastrointestinal reflux disease on upper- and lower-respiratory symptoms
Describe the differential diagnosis for nocturnal cough
Select appropriate medications for allergic rhinitis therapy based on the overall patient profile
Back to TopProgram content and discussions may
include information regarding the use of products that may be
inconsistent with or outside the approved labeling for these products in
the United States. Participants should note that uses of these products
outside the current approved labeling
are considered experimental and are advised to consult prescribing
information for these products.
Sponsor
This activity is sponsored by the Pragmaton Office of Medical Education and is supported by an
unrestricted educational grant from
Merck & Co., Inc.
Accreditation Statements Physician Accreditation Statement
The Pragmaton Office of Medical Education (POME) is
accredited by the Accreditation Council for Continuing Medical Education (ACCME)
to provide continuing medical education for physicians.
Physician Designation Statement
The Pragmaton Office of Medical Education designates
this educational activity for a maximum of 1 hour in category 1 credit toward
the AMA Physician’s Recognition Award. Each physician should claim only those
hours of credit that he/she actually spent in the activity.
American Academy of Family Physicians Designation Statement
This activity has been reviewed and is acceptable
for up to 1 Prescribed credit hour by the American Academy of Family
Physicians. Term of approval is for one year from beginning distribution
date of November 15, 2001, with option to request yearly renewal.
Statement for Other Healthcare Professionals
A certificate of participation for 1 hour will be
issued to all Healthcare Professionals not covered by the other accreditation
statements listed.
Back to Top
Faculty Disclosure Policy
It is the policy of the Pragmaton Office of Medical Education that
faculty members of CME/CE-accredited programs must disclose any
significant financial interest, arrangement, or affiliation with a
corporate organization that may have an impact on the faculty member’s
presentation, such as grants, research support, honoraria, member of
speakers’ bureau, consultant, major stock shareholder, etc.
Faculty Disclosures
Michael S. Blaiss, MD Formal advisor: GSK; Merck & Co., Inc.
Researcher: GSK; Merck & Co., Inc. Educational consultant: Merck
& Co., Inc. Speakers’ bureau: GSK; Aventis Pharmaceuticals; Merck
& Co., Inc.; Schering Corporation. Stockholder: Merck & Co.,
Inc.
Phillip Lieberman, MD
Formal advisor: Wallace Laboratories;
AstraZeneca. Researcher: Wallace Laboratories. Educational consultant:
Wallace Laboratories; Glaxo Wellcome Inc. Speakers’ bureau: Wallace
Laboratories; Glaxo Wellcome Inc.; Schering Corporation; AstraZeneca;
Merck & Co., Inc.; Aventis Pharmaceuticals.
Back to TopPragmaton Office of Medical Education Mission Statement
Our
mission is to promote excellence in continuing professional medical
education by developing and implementing activities that meet national
and regional healthcare needs. In these objective, fair, and balanced
activities, we strive to transfer new knowledge and skills into the
clinical setting, improve professional practice, and enhance patient
care.
Areas of expertise include women's health, cardiology, neurology,
psychiatry, endocrinology, and ophthalmology. Because of the scope and
content of programming, the Pragmaton Office of Medical Education
develops a variety of multidisciplinary activities for primary and
specialty care physicians, nurses, pharmacists, and other allied
healthcare professionals. Methods of educational delivery include live
presentations, self-study materials, and interactive electronic media,
including use of the Internet.
In addition, the Pragmaton Office of Medical Education has established collaborative relationships with
nonaccredited providers who share our mission in meeting national and regional healthcare needs.
The Pragmaton Office of Medical Education, under the guidance of both a
Physician and Pharmacist Advisory Board, is supported by Pragmaton’s
senior management and receives support and commitment from healthcare
companies.
Back to TopPragmaton Office of Medical Education Privacy Policy
The
Pragmaton Office of Medical Education (POME) does not sell or offer any
user data, including registration or billing information to any third
party for commercial purposes. POME does, where required, provide the
minimum subset of information to those third parties that are
responsible for accreditation and issuance of certification of
Continuing Education tests submitted. You agree that POME has full
permission to provide this minimum subset of information to the third
parties as required by law.
To provide additional security in those cases where a credit
card number or other form of payment has been submitted, POME utilizes
this information once, but does not permanently store this information.
Therefore, it will be necessary for you to reenter billing information
during subsequent visits. Although this may create a minor
inconvenience, POME believes that security should be first and foremost
in the provision of its services and therefore will not store billing
information permanently in its records.
Back to Top